Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains

Citation
Me. Jones et al., Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains, ANTIM AG CH, 43(2), 1999, pp. 421-423
Citations number
17
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
43
Issue
2
Year of publication
1999
Pages
421 - 423
Database
ISI
SICI code
0066-4804(199902)43:2<421:CAOCGL>2.0.ZU;2-Y
Abstract
The activities of eight fluoroquinolones and linezolid, quinupristin-dalfop ristin (Synercid), gentamicin, and vancomycin were tested against 96 ciprof loxacin-susceptible and 205 ciprofloxacin-resistant Staphylococcus aureus s trains. Overall, clinafloxacin, followed by moxifloxacin and trovafloxacin, was the most active quinolone tested. For all isolates, linezolid and quin upristin-dalfopristin showed activities that were at least comparable to va ncomycin, with no cross-resistance to any other test compound.